eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial

BACKGROUND: Bevacizumab plus chemotherapy is a widely used therapeutic option for first-line treatment of metastatic colorectal cancer (mCRC). However, molecular predictors of bevacizumab efficacy have not yet been identified. We analyzed vascular endothelial growth factor (VEGF) and endothelial nit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Ulivi, Paola, Scarpi, Emanuela, Passardi, Alessandro, Marisi, Giorgia, Calistri, Daniele, Zoli, Wainer, Del Re, Marzia, Frassineti, Giovanni Luca, Tassinari, Davide, Tamberi, Stefano, Vertogen, Bernadette, Amadori, Dino
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4531503/
https://ncbi.nlm.nih.gov/pubmed/26259598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0619-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados